2.47
Reviva Pharmaceuticals Holdings Inc Azioni (RVPH) Dati Finanziari
Conto economico
Trimestrale
*Tutti i numeri sono espressi in milioni
| Data di fine periodo | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 |
| Durata del periodo | 3 mesi | 3 mesi | 3 mesi | 3 mesi | 3 mesi |
| Revenues |
-
|
- | - | - | - |
|
|
33.64%
4.0298
|
6.073 | 6.5382 | 6.2846 | 8.4625 |
| Operating Income/Loss |
33.64%
-4.0298
|
-6.073 | -6.5382 | -6.2846 | -8.4625 |
| Nonoperating Income/Loss |
19.83%
0.0219
|
0.0273 | 0.1105 | 0.0299 | 0.0967 |
| Income/Loss From Continuing Operations Before Tax |
33.71%
-4.0079
|
-6.0457 | -6.4276 | -6.2547 | -8.3658 |
| Income Tax Expense/Benefit |
64.29%
0.00284
|
0.00795 | 0.00521 | 0.00473 | - |
| Income/Loss From Continuing Operations After Tax |
33.75%
-4.0108
|
-6.0536 | -6.4328 | -6.2595 | -8.3658 |
|
|
33.75%
-4.0108
|
-6.0536 | -6.4328 | -6.2595 | -8.3658 |
| Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
| Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
| Basic Average Shares |
45.82%
72.69
|
49.85 | 48.64 | 1.723 | 33.80 |
| Basic Earnings Per Share |
50.00%
-0.06
|
-0.12 | -0.13 | -0.15 | -0.25 |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):